{"nct_id":"NCT06550895","title":"A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-09-16","start_date_type":"ACTUAL","primary_completion_date":"2026-08-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-08-31","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["JNJ"]}